Corneal grafting for keratoconus in mentally retarded patients

被引:15
|
作者
Haugen, OH [1 ]
Hovding, G
Eide, GE
Bertelsen, T
机构
[1] Haukeland Univ Hosp, Dept Ophthalmol, N-5021 Bergen, Norway
[2] Haukeland Univ Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[3] Univ Bergen, Sect Med Stat, N-5020 Bergen, Norway
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2001年 / 79卷 / 06期
关键词
keratoconus; mental retardation; penetrating keratoplasty; non-penetrating keratoplasty; graft survival; postoperative complications;
D O I
10.1034/j.1600-0420.2001.790612.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the results of penetrating and non-penetrating corneal grafting procedures in mentally retarded keratoconus patients. Methods: In the years 1974-2000 41 mentally retarded patients with keratoconus (33 with Down syndrome) were operated with corneal grafting. Mean age at operation was 36.7 +/- 10.8 years. Three different surgical procedures were used (no randomization): penetrating keratoplasty (n=16), lamellar keratoplasty (n=5) and epikeratophakia (n=20). In a retrospective study the non-penetrating procedures (lamellar keratoplasty and epikeratophakia) were compared to the penetrating keratoplasties with regard to graft survival and frequency of serious complications. Mean follow-up time of all grafting procedures was 80 +/- 58 months. Results: All cases of serious complications (irreversible rejection, wound leakage or perforation) occurred in the penetrating, keratoplasty group (p=0.0005). Older age at operation (p=0.011) adversely influenced the frequency of serious complications. Overall five-year survival was 74.9%. Graft survival was not related to surgical procedure, but rather to age at operation (poorer survival in older age, p=0.012) and degree of retardation (poorer survival in patients with more severe retardation, p=0.051). Conclusions: Because of the safety and low frequency of complications, epikeratophakia is recommended as the grafting procedure of choice in the majority of mentally retarded with keratoconus. In selected cases (good cooperation, age less than or equal to 40 years, and a good peripheral corneal thickness) penetrating keratoplasty may be performed, which, if uncomplicated, often will give better functional/optical results.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 50 条
  • [31] SEIZURE CONTROL IN MENTALLY-RETARDED PATIENTS
    HO, SU
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (03): : 372 - 372
  • [32] Retrospective karyotype study in mentally retarded patients
    Teixeira, Wellcy Goncalves
    Marques, Fabiana Kalina
    Menezes Freire, Maira Cristina
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (03): : 262 - 268
  • [33] Birth patterns in mentally retarded autistic patients
    Yeates-Frederikx, MHM
    Nijman, H
    Logher, E
    Merckelbach, HLGJ
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (03) : 257 - 262
  • [34] Cytogenetics study in severely mentally retarded patients
    Yasseen, AA
    Al-Musawi, TA
    SAUDI MEDICAL JOURNAL, 2001, 22 (05) : 444 - 449
  • [35] Cytogenetic Analysis of Mentally Retarded Patients in Srikakulam
    Mythili, K.
    Kumari, V. Jaya
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2011, 11 (03) : 183 - 192
  • [36] Birth Patterns in Mentally Retarded Autistic Patients
    M. H. M. Yeates-Frederikx
    H. Nijman
    E. Logher
    H. L. G. J. Merckelbach
    Journal of Autism and Developmental Disorders, 2000, 30 : 257 - 262
  • [37] ORAL MANIFESTATIONS IN A GROUP OF MENTALLY RETARDED PATIENTS
    SANDLER, ES
    ROBERTS, MW
    WOJCICKI, AM
    JOURNAL OF DENTISTRY FOR CHILDREN, 1974, 41 (03): : 47 - 51
  • [38] Our Sedation Experience on Mentally Retarded Patients
    Alkan, Metin
    Kip, Gulay
    Sahin, Saziye
    Atac, Mustafa Sancar
    Kilinc, Yeliz
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 (04) : 423 - 427
  • [39] Effects of estazolam as a premedication in mentally retarded patients
    Kanmura Y.
    Kamihashi M.
    Journal of Anesthesia, 1997, 11 (1) : 14 - 17
  • [40] VIGABATRIN IN EPILEPSY IN MENTALLY-RETARDED PATIENTS
    MATILAINEN, R
    PITKANEN, A
    RUUTIAINEN, T
    MERVAALA, E
    RIEKKINEN, P
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 : S113 - S118